Zustand: As New. Unread book in perfect condition.
Zustand: New.
EUR 26,69
Anzahl: 6 verfügbar
In den WarenkorbZustand: New.
EUR 29,46
Anzahl: 6 verfügbar
In den WarenkorbZustand: As New. Unread book in perfect condition.
Sprache: Englisch
Verlag: Vfmk Verlag für moderne Kunst GmbH, 2026
ISBN 10: 399153214X ISBN 13: 9783991532149
Anbieter: moluna, Greven, Deutschland
Zustand: New.
Sprache: Englisch
Verlag: Academic Press 2016-02-05, 2016
ISBN 10: 0128022086 ISBN 13: 9780128022085
Anbieter: Chiron Media, Wallingford, Vereinigtes Königreich
EUR 121,12
Anzahl: Mehr als 20 verfügbar
In den WarenkorbHardcover. Zustand: New.
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
EUR 138,37
Anzahl: 2 verfügbar
In den WarenkorbHardcover. Zustand: Brand New. 1st edition. 498 pages. 9.50x8.00x1.00 inches. In Stock.
Sprache: Englisch
Verlag: Elsevier Science Publishing Co Inc, 2015
ISBN 10: 0128022086 ISBN 13: 9780128022085
Anbieter: THE SAINT BOOKSTORE, Southport, Vereinigtes Königreich
EUR 150,16
Anzahl: Mehr als 20 verfügbar
In den WarenkorbHardback. Zustand: New. New copy - Usually dispatched within 4 working days.
Anbieter: Brook Bookstore On Demand, Napoli, NA, Italien
EUR 110,38
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: new. Questo è un articolo print on demand.
Sprache: Englisch
Verlag: Elsevier Science Dez 2015, 2015
ISBN 10: 0128022086 ISBN 13: 9780128022085
Anbieter: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Deutschland
Buch. Zustand: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Drug Discovery in Cancer Epigenetics is a practical resource for scientists involved in the discovery, testing, and development of epigenetic cancer drugs. Epigenetic modifications can have significant implications for translational science as biomarkers for diagnosis, prognosis or therapy prediction. Most importantly, epigenetic modifications are reversible and epigenetic players are found mutated in different cancers; therefore, they provide attractive therapeutic targets. There has been great interest in developing and testing epigenetic drugs, which inhibit DNA methyltransferases, histone modifying enzymes or chromatin reader proteins. The first few drugs are already FDA approved and have made their way into clinical settings. This book provides a comprehensive summary of the epigenetic drugs currently available and aims to increase awareness in this area to foster more rapid translation of epigenetic drugs into the clinic. 498 pp. Englisch.
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Buch. Zustand: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Drug Discovery in Cancer Epigenetics is a practical resource for scientists involved in the discovery, testing, and development of epigenetic cancer drugs. Epigenetic modifications can have significant implications for translational science as biomarkers for diagnosis, prognosis or therapy prediction. Most importantly, epigenetic modifications are reversible and epigenetic players are found mutated in different cancers; therefore, they provide attractive therapeutic targets. There has been great interest in developing and testing epigenetic drugs, which inhibit DNA methyltransferases, histone modifying enzymes or chromatin reader proteins. The first few drugs are already FDA approved and have made their way into clinical settings. This book provides a comprehensive summary of the epigenetic drugs currently available and aims to increase awareness in this area to foster more rapid translation of epigenetic drugs into the clinic.